GCANRx

Curated by Signal

Developer of cannabinoid drug delivery systems

Overview

Developer of cannabinoid drug delivery systems. The company has a drug-eluting transmucosal patch platform for non-invasive intra-oral drug delivery. It allows the controlled release of drugs directly into the blood system while bypassing the digestive and hepatic systems.

Key facts

Founded: 2018
Headquarters: Baltimore, United States
Stage: Sign up to view
Industry: Health Technology

Business model

1 product or service: Sign up to view

Contact

Email: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

Circuit Clinical
Research site network platform focuses on patient identification, enrollment, recruitment & retention
Health TechnologyBuffalo, United States
Prendio
Provider of supply chain management solutions for biotech, finance, and other industries
Health TechnologyWoburn, United States
Practical Health Systems
Provider of web-based healthcare software for disabled people
Health TechnologyNashville, United States

About GCANRx

What does GCANRx do?

Developer of cannabinoid drug delivery systems.

Where is GCANRx headquartered?

GCANRx is headquartered in Baltimore, United States.

When was GCANRx founded?

GCANRx was founded in 2018.

Which sector is GCANRx in?

GCANRx operates in Health Technology.

Who are GCANRx's competitors?

Companies similar to GCANRx include Circuit Clinical, Prendio, and Practical Health Systems.